Declining breast cancer incidence and decreased HRT use.
about
Population pharmacokinetics of the humanised monoclonal antibody, HuHMFG1 (AS1402), derived from a phase I study on breast cancer.Recent breast cancer incidence trends according to hormone therapy use: the California Teachers Study cohortThe potential association between postmenopausal hormone use and primary open-angle glaucoma.Nation-wide Korean breast cancer data from 2008 using the breast cancer registration program.Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality databaseBreast cancer risk in relation to the interval between menopause and starting hormone therapy.Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort studyGeneral Practitioners and Breast Surgeons in France, Germany, Netherlands and the UK show variable breast cancer risk communication profilesRadiation therapy in early-stage invasive breast cancer.Breast cancer incidence and menopausal hormone therapy in Norway from 2004 to 2009: a register-based cohort studyHigh burden of breast cancer in Belgium: recent trends in incidence (1999-2006) and historical trends in mortality (1954-2006).Recent changes in breast cancer incidence in Spain, 1980-2004.Risk factors for breast cancer: epidemiological evidence from Japanese studies.Hormone replacement therapy and the risk of breast cancer.Hormone therapy and breast cancer risk 10 years after the WHI.Near-infrared imaging of breast cancer using optical contrast agents.Systematic review about breast cancer incidence in relation to hormone replacement therapy use.Breast cancer incidence trends in European women aged 20-39 years at diagnosis.Menopausal hormone therapy use and breast cancer risk in Australia: Findings from the New South Wales Cancer, Lifestyle and Evaluation of Risk study.Time trends in breast cancer and menopause hormone therapy use in New Zealand.Association between recent herpes zoster but not herpes simplex infection and subsequent risk of malignancy in women: a retrospective cohort study.Recent declines in breast cancer incidence: mounting evidence that reduced use of menopausal hormones is largely responsible.Estrogen receptor mediates the effects of pseudoprotodiocsin on adipogenesis in 3T3-L1 cells.Breast cancer incidence and use of hormone therapy in Denmark 1978-2007.Declining breast cancer incidence and decreased HRT useBehavioural cancer risk factors in women diagnosed with primary breast cancer.Hormone therapy use and breast cancer incidence by histological subtypes in Sweden and Norway.Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case-control study.Positron emission tomography-computed tomography in the detection of axillary lymph node metastasis in patients with early stage breast cancer.The Science of Marketing: How Pharmaceutical Companies Manipulated Medical Discourse on Menopause
P2860
Q33708140-265B11CD-2CCD-4843-AD02-C15EE89D184AQ33892873-5792DECC-CE1A-4D16-B535-105F2B961439Q33930485-13D1E08C-4CA1-41F8-A733-AC774F635094Q34059559-3EFD29A3-21B1-42D8-90F7-6E91E7D12E50Q34061266-109727AE-75D7-4F9F-AE40-2F17C449E89DQ34577224-8BF26CF7-33CB-4A92-BEC6-6CF601162B94Q35077931-978F9C00-BAC7-47EE-BE59-1B7E152923A2Q35372433-7472BE68-5789-40CB-A997-78FABEFAD726Q35628076-C0DD8758-431C-4111-B57B-8B6446DB6C47Q36023930-6F70E925-5BF0-4088-B122-8412D3D730A3Q36217532-966C57C9-82D2-4645-A7EB-9AE3E6F323C8Q37424360-8964BBCD-E63E-4B51-9F59-60B8699735D5Q37882033-34B59919-A665-4448-9C5B-BCA1766DF221Q37909897-53B8B342-892B-4C83-BB0A-7D1A34D33D65Q38011782-129EA1D3-68DA-4AB5-8805-191BDC0FA895Q38058281-C39715AE-9B5E-4C49-8B4E-67C4B3706B93Q38126067-C0D2A9B2-F781-490C-A0E5-1A9296FB077EQ38433572-CE5EBE0A-F0C3-4D14-9A31-30B17F68B241Q40283293-7CD8EA0C-8652-414B-9226-E6BBCB478496Q40315288-CE65DB9E-406F-49E1-9C64-87B61DDA840FQ42279778-3C10F433-3C51-4C6A-B445-7B080D38AE14Q42761898-332680AF-EB3A-4D02-8F4A-C549C1B3A78CQ42827165-7FB7C0A5-CD78-440B-A5CB-5AC0C5631702Q44395164-F7B1EE46-83B1-4B51-9B7C-FC3A446D06D9Q44935770-38f54b2d-4838-4be5-d9c5-be2a7689d3f4Q45784584-F795787F-EF7D-4E2E-877D-75FF19072002Q46260981-F9288944-7ED7-458C-95BC-C6205823D2C2Q47635634-24CEB73E-85AD-45DC-80FC-85EDCC56196DQ53362640-6D0A7500-E35D-4635-849D-5882EF34619FQ56672983-6001E988-46F3-4AA2-A9FF-024EA7E6A554
P2860
Declining breast cancer incidence and decreased HRT use.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel by Kumle from august 2018
@da
vědecký článek
@cs
name
Declining breast cancer incidence and decreased HRT use.
@en
Declining breast cancer incidence and decreased HRT use.
@nl
type
label
Declining breast cancer incidence and decreased HRT use.
@en
Declining breast cancer incidence and decreased HRT use.
@nl
prefLabel
Declining breast cancer incidence and decreased HRT use.
@en
Declining breast cancer incidence and decreased HRT use.
@nl
P1433
P1476
Declining breast cancer incidence and decreased HRT use.
@en
P2093
Merethe Kumle
P304
P356
10.1016/S0140-6736(08)61255-6
P407
P577
2008-08-01T00:00:00Z